Physician profile

Dilys A Whyte

Pediatric Nephrology · West Islip, NY

NPI 1760424881

$2,508.46

in general payments reported to CMS, 2019-2025

40 companies · $482 in 2025

The $482 reported for 2025 was more than what 75% of Pediatric Nephrology providers received nationally (typical 2025 total: $131).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$1,551.89

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Mallinckrodt Enterprises LLC $247.62 2019
Genzyme Corporation $246.56 2021-2024
Corium, LLC $213.77 2023-2025 Azstarys
Supernus Pharmaceuticals, INC. $175.13 2022-2025 Qelbree, Qelbree
Ironshore Pharmaceuticals INC. $164.52 2019-2024 Jornay Pm
Neurelis, INC. $117.00 2020-2024 Valtoco
Ucb, INC. $114.89 2022-2025 Fintepla, Cimzia
Alexion Pharmaceuticals, INC. $98.05 2024-2025 Koselugo, Strensiq
Sunovion Pharmaceuticals INC. $66.77 2019
Baxter Healthcare $66.48 2023-2025 Hillrom - Life 2000 Ventilation System, Hillrom - Vest System Model 105 Home Care
Global Blood Therapeutics, INC. $60.04 2020-2022
Tandem Diabetes Care, INC. $59.54 2022-2024 T:Slim X2 Insulin Pump With Control-Iq
Medtronic, INC. $59.26 2024 Minimed 780g
Azurity Pharmaceuticals, INC. $59.25 2025 Triptodur
Takeda Pharmaceuticals U.S.A., INC. $56.58 2024-2025 Eohilia
Show all 40 companies
CompanyGeneral paymentsYearsTop products
Acadia Pharmaceuticals INC $52.75 2023-2024 Daybue
Neos Therapeutics, Lp $51.76 2023-2025 Adzenys Xr-Odt, Cotempla Xr-Odt
Ascendis Pharma Endocrinology INC $47.72 2025 Skytrofa
Glaxosmithkline, LLC. $43.28 2021-2023 Nucala
Vertical Pharmaceuticals, LLC $41.26 2019
Abbvie INC. $38.41 2025
Greenwich Biosciences, INC. $34.53 2019-2021
Collegium Pharmaceutical, INC. $32.46 2025 Jornay Pm
Biomarin Pharmaceutical INC. $31.46 2022-2023 Voxzogo 1.2mg
Novo Nordisk INC $31.28 2020-2024 Rivfloza
Sobi, INC $31.25 2023
Grifols USA, LLC $29.59 2025 Xembify
Ultragenyx Pharmaceutical INC. $27.73 2019-2021
Mirum Pharmaceuticals, INC. $23.34 2023 Livmarli
Catalyst Pharmaceuticals, INC. $22.44 2024
Zogenix INC. $22.01 2021
Xeris Pharmaceuticals, INC. $21.32 2024 Gvoke Hypopen
Leadiant Biosciences, INC. $18.35 2019
Boehringer Ingelheim Pharmaceuticals, INC. $16.84 2020
Ferring Pharmaceuticals INC. $15.73 2020
Cranial Technologies, INC $14.90 2020
Adlon Therapeutics L.P. $14.22 2020
Tris Pharma INC $13.98 2020
Janssen Biotech, INC. $13.65 2025 Tremfya
Cognoa, INC. $12.74 2022

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Dilys A Whyte

$2,508.46

in general payments reported 2019-2025

Years
2019-2025
Top company
Mallinckrodt Enterprises LLC
Context
The $482 reported for 2025 was more than what 75% of Pediatric Nephrology providers received nationally (typical 2025 total: $131).

https://glasscript.com/doctor/1153611/dilys-a-whyte

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.